Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Market Insight: Best practice in investigator relationship management

This article was originally published in Scrip

Executive Summary

The concept of a biopharmaceutical company, a medical devices firm or a CRO striving to become recognised by independent clinical trial sites as a "sponsor of choice" was almost unheard of less than a decade ago. Yet, the clinical research landscape has evolved and competition for high-performing sites, particularly in the US, has increased. In response, sponsors are working with sites to increase their productivity and to facilitate better working relationships between the parties. Clearly, the stakes are high: late-stage clinical trial failures or delays translate commercially into shortfalls in forecasted revenues and shorter periods of marketing exclusivity.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC030965

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel